DocuSign (DOCU) appoints Mike Rosenbaum to Board; Chair named Sept 4, 2025

DocuSign, Inc. reported results for the three and six months ended July 31, 2025 via a press release furnished as Exhibit 99.1 to this Current Report.

Rhea-AI Filing Summary

DocuSign, Inc. reported results for the three and six months ended July 31, 2025 via a press release furnished as Exhibit 99.1 to this Current Report. The Company announced the appointment of Mike Rosenbaum to the Board effective September 3, 2025 as a Class III director whose term expires at the Company’s 2027 Annual Meeting of Stockholders. The Board determined Mr. Rosenbaum is an independent director, there are no arrangements or related‑party interests requiring disclosure, and he will receive compensation under the Company’s existing Amended and Restated Director Compensation Program. Mr. Rosenbaum has also entered the Company’s standard indemnity agreement. The press release also announces James Beer as Board Chair; these disclosures are furnished under Regulation FD and are not "filed" for Section 18 liability.

Positive

• Board independence maintained with the appointment of an independent director
• Governance clarity with appointment of James Beer as Board Chair
• No related‑party interests disclosed for the new director
• Compensation and indemnity tied to existing, previously filed programs

Negative

• None.

Insights

Corporate Governance Expert

Board strengthened with an independent director and a named Chair.

The appointment of Mike Rosenbaum as a Class III director and the naming of James Beer as Board Chair signal a governance update effective September 3, 2025. The filing explicitly states Mr. Rosenbaum qualifies as an independent director and has no related‑party interests, which supports board independence and oversight.

This change is relevant to shareholders because board composition and independent leadership affect oversight of management and strategic decisions; Mr. Rosenbaum’s term runs until the 2027 Annual Meeting.

Legal & SEC Compliance Expert

Disclosure follows SEC rules and limits incorporation by reference.

The Company furnished a press release (Exhibit 99.1) reporting financial results and the board changes and clarified the exhibit is "furnished" not "filed," limiting Section 18 liability and incorporation into other filings unless specifically referenced. The filing cites the director compensation program and the Company’s standard indemnity agreement as prior exhibits, linking compensation and indemnity to previously filed documents.

This is a routine Form 8‑K disclosure; there are no new financial statements or material contracts attached in this filing.

8-K Event Classification

4 items: 2.02, 5.02, 7.01, 9.01

4 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

What changes did DocuSign (DOCU) disclose on its Form 8‑K?

The Form 8‑K furnished a press release with financial results and announced the appointment of Mike Rosenbaum to the Board effective September 3, 2025 and the appointment of James Beer as Board Chair.

When does Mike Rosenbaum's director term expire at DOCU?

Mr. Rosenbaum will serve as a Class III director with a term that expires at the Company’s 2027 Annual Meeting of Stockholders.

Is Mike Rosenbaum considered independent under DOCU's disclosure?

Yes. The Board determined Mr. Rosenbaum qualifies as an independent director under applicable listing standards, and the filing states he has no direct or indirect material interest requiring Item 404 disclosure.

Will DOCU disclose Mr. Rosenbaum's compensation in this filing?

The filing states Mr. Rosenbaum will be paid under the Company’s Amended and Restated Director Compensation Program, which is attached as Exhibit 10.1 to a prior quarterly report; specific payments are not detailed in this 8‑K.

Does this 8‑K include audited financial statements or material agreements?

No. The filing furnishes a press release and references prior exhibits for compensation and indemnity; it does not attach new audited financial statements or material contracts in this entry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/04/2025 - 04:07 PM Learn about SEC filing dates

0001261333FALSE00012613332025-09-032025-09-03

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

______________________________________

FORM 8-K

______________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 3, 2025

Commission File Number: 001-38465

______________________________________

DOCUSIGN, INC.

(Exact name of registrant as specified in its charter)

______________________________________

Delaware

91-2183967

(State or Other Jurisdiction of Incorporation)

(I.R.S. Employer Identification Number)

221 Main St.

Suite 800

San Francisco

California

94105

(Address of Principal Executive Offices) (Zip Code)

(415) 489-4940

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

¨			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol			Name of each exchange on which registered
Common Stock, par value $0.0001 per share			DOCU			The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02    Results of Operations and Financial Condition.

On September 4, 2025, Docusign, Inc. (the “Company”) reported financial results for the three and six months ended July 31, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The press release is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information in this Item 2.02 and in the accompanying Exhibit 99.1 shall not be deemed incorporated by reference into any registration statement or other filing with the Securities and Exchange Commission (the “SEC”) made by the Company, whether made before or after the date of this Current Report, regardless of any general incorporation language in such filing, except as shall be expressly set forth by specific references in such filing.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d)

Following the recommendation of the Company’s Nominating and Corporate Governance Committee of the Board of Directors (the “Board”), the Board appointed Mike Rosenbaum to fill a vacancy on the Board to serve as a director of the Company, effective September 3, 2025. Mr. Rosenbaum will serve as a Class III director whose term will expire at the Company’s 2027 Annual Meeting of Stockholders, which is the next stockholder meeting at which Class III directors will be elected, and until Mr. Rosenbaum’s successor shall have been duly elected and qualified, or until Mr. Rosenbaum’s earlier death, resignation, disqualification or removal. The Board determined that Mr. Rosenbaum qualifies as an independent director pursuant to the Securities Act of 1933, as amended, and the listing standards of the Nasdaq Stock Market.

There is no arrangement or understanding between Mr. Rosenbaum and any other person pursuant to which Mr. Rosenbaum was selected as a director. Mr. Rosenbaum has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Mr. Rosenbaum will receive compensation for his service as a member of the Board in accordance with the Company’s Amended and Restated Director Compensation Program, which is attached as Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on September 7, 2023.

Mr. Rosenbaum has also entered into the Company’s standard form of indemnity agreement, which is attached as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on December 3, 2020.

Item 7.01. Regulation FD Disclosure.

A press release dated September 4, 2025, announcing Mr. Rosenbaum’s appointment to the Board and James Beer’s appointment as Board Chair is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information in Item 7.01 of this current report, including Exhibit 99.1 attached hereto, is furnished and shall not be treated as filed for purposes of the Securities Exchange Act of 1934, as amended

Item 9.01     Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.			Description
99.1			Press Release dated September 4, 2025 concerning financial results
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: September 4, 2025

			DOCUSIGN, INC.
			By:			/s/ Blake Grayson
						Blake Grayson
						Chief Financial Officer
						(Principal Accounting and Financial Officer)